Molecular Partners Ag (MOLN) Net Income towards Common Stockholders (2021 - 2025)
Historic Net Income towards Common Stockholders for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to -$14403.4.
- Molecular Partners Ag's Net Income towards Common Stockholders fell 1006.35% to -$14403.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.9 million, marking a year-over-year increase of 10007.12%. This contributed to the annual value of -$61.4 million for FY2024, which is 1208.85% up from last year.
- Latest data reveals that Molecular Partners Ag reported Net Income towards Common Stockholders of -$14403.4 as of Q3 2025, which was down 1006.35% from $4.7 million recorded in Q2 2025.
- Molecular Partners Ag's Net Income towards Common Stockholders' 5-year high stood at $165.2 billion during Q1 2022, with a 5-year trough of -$18.2 billion in Q1 2024.
- Moreover, its 5-year median value for Net Income towards Common Stockholders was -$16136.5 (2025), whereas its average is $8.9 billion.
- Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first skyrocketed by 90218183697.23% in 2022, then crashed by 26066.73% in 2023.
- Quarter analysis of 5 years shows Molecular Partners Ag's Net Income towards Common Stockholders stood at $51.7 billion in 2021, then tumbled by 99.76% to $122.2 million in 2022, then tumbled by 100.77% to -$934828.2 in 2023, then soared by 981.48% to $8.2 million in 2024, then crashed by 100.17% to -$14403.4 in 2025.
- Its Net Income towards Common Stockholders was -$14403.4 in Q3 2025, compared to $4.7 million in Q2 2025 and -$16136.5 in Q1 2025.